For patients with SAP- associated liver damage, glycocalyx-mimetic nanoparticles are expected to transport drugs and target them to the liver while controlling inflammation
Diabetes Obes Metab 25(1):5667 Rosenstock J, Wysham C, Frias JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Table 5 summarizes key therapeutic candidates under clinical evaluation or recently approved, highlighting their mechanism of action, clinical stage, and therapeutic targets
Here, we also observed reduced urinary levels of the endogenous parent estrogens (E2 and E1) in COC users (Table 1)
Combining DSIP with other anxiety-modulating peptides like Selank may enhance stress-related benefits, though this adds complexity to the protocol and increases the importance of proper medical guidance